X BODY

X-BODY is a biotechnology company that discovers and develops compounds against targets in oncology and ophthalmology. The company's mission is to apply its innovative capabilities to the discovery of human antibodies against high-value therapeutic targets. X-BODY has entered into a number of alliances with other corporations to generate antibody therapeutic candidates. X-BODY's internal efforts are focused on discovering and developing compounds against biologically relevant targets in oncology and ophthalmology. X-BODY was formed in 2008 by industry veterans Richard Wagner, Brant Binder, and Gordon Binder.